Mac-Chem

What Mac-Chem does

Mac-Chem Products (India) Pvt. Ltd. is an Indian Active Pharmaceutical Ingredient (API) manufacturer and formulation producer, established in 2010 as part of the NMM Group founded by Mr B.K. Jain in 1985. The company specializes in three API categories — Oncology APIs (35+ molecules including Abiraterone, Bortezomib, Capecitabine, Docetaxel, Imatinib, Paclitaxel and Zoledronic Acid), Lyophilized Bulk Sterile APIs (freeze-dried sterile ingredients for injectables including Acyclovir, Colistimethate Sodium and Pantoprazole Sodium), and General APIs (muscle relaxants, antibiotics, antiemetics, corticosteroids and sedatives). Its Boisar, Maharashtra facility holds cGMP certifications from US-FDA, EDQM, COFEPRIS, ANVISA, MFDS-Korea, WHO-GMP and ISO, enabling supply to pharmaceutical customers across 40+ countries. Core technical capabilities include Cat III & IV containment for cytotoxic handling, three lyophilizers (140L and 400L capacities) representing capability built since the early 1990s, a DSIR-approved R&D lab with 41 scientists, and the only deployment in India outside Cipla of LABWARE LIMS plus an exclusive Indian deployment of MASTER CONTROL QMS.

The company extends beyond APIs into finished formulation products marketed under the Naprod sub-brand, covering anti-neoplastic, anesthesia and general injectable formulations, with a disclosed product pipeline including Bendamustine RTU, Pralatraxate, Dasatinib and Ibrutinib. It employs approximately 800 professionals across four manufacturing locations, serves 570+ clients with 83 products delivered, and invests 8% of revenue in R&D to develop 10-12 new generic molecules annually. Its business model is B2B enterprise direct sales via dedicated Business Development Managers for domestic and export markets, with revenue generated through one-time API sales contracts and dossier out-licensing in emerging markets; pricing is not publicly disclosed and is negotiated on a per-contract basis. Named customers include Cipla, Sun Pharma, Zydus, Dr. Reddy's, Glenmark, Intas, Lupin, GSK, Sanofi, STADA and Orion among others. The company's stated long-term goal is to derive 50%+ of turnover from exports to regulated markets (USA, Europe, semi-regulated), supported by plans to appoint own representatives in international markets.

Name

Mac-Chem

Legal name

Mac-Chem Products (India) Pvt. Ltd.

Website

https://macchemgroup.com

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Mac-Chem is an Indian API manufacturer and formulation producer specializing in oncology, lyophilized bulk sterile, and general APIs for pharmaceutical companies globally. Operating from Boisar with US-FDA and EDQM certifications, it serves 570+ clients across 40+ countries.

Ownership category

akta.pro rank

Product category

Active Pharmaceutical Ingredients (APIs)

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834), Medicinal Chemicals & Botanical Products (2833)

akta.pro industry

PRIMARYHLAGAHAM

Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services

SECONDARYHLAIALAD

CMC & Pharmaceutical Development (Formulation/Process/Analytical Development)

Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Research and Development

Keywords

• Active pharmaceutical ingredients
• Oncology API manufacturing
• Lyophilized sterile injectables
• Generic drug development
• Pharmaceutical contract manufacturing

Headquarters

HQ city

Andheri

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. API Manufacturing and Sales: Mac-Chem generates revenue through manufacturing and sale of Active Pharmaceutical Ingredients including Oncology APIs, General APIs, and Lyophilized Bulk Sterile APIs to pharmaceutical companies globally.
2. Dossier Licensing: Mac-Chem develops dossiers approved by regulators from different countries available for out-licensing in emerging markets.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels2 records

Core offering

Mac-Chem manufactures and supplies Active Pharmaceutical Ingredients (APIs) including Oncology APIs, Lyophilized Bulk Sterile APIs, and General APIs to pharmaceutical companies globally. The company also produces finished dosage formulations (anti-neoplastic, anesthesia, and general therapeutic categories) from a US-FDA, EDQM, COFEPRIS, ANVISA, MFDS-Korea, WHO-GMP and ISO certified cGMP facility in Boisar, Maharashtra, and out-licenses regulatory dossiers in emerging markets.

Product overview

Mac-Chem is a pharmaceutical manufacturing company within the NMM Group, specializing in Active Pharmaceutical Ingredients (APIs) and finished dosage formulations. The company operates four manufacturing plants employing approximately 800 professionals, with facilities in Boisar, Maharashtra. Mac-Chem's product portfolio is organized into three main API categories: Oncology APIs (specialized cancer treatment ingredients), Lyophilized Bulk Sterile APIs (freeze-dried sterile ingredients for injectables), and General APIs (muscle relaxants, antibiotics, antiemetics, anesthetics, and corticosteroids). Complementing the API business, Mac-Chem produces finished formulation products including Anti-neoplastic Formulations (cancer treatment tablets, capsules, and injectables), Anesthesia Formulations (injectable anesthetic and muscle relaxant products), and General Formulations (lyophilized injectable products for various therapeutic applications). The company also maintains a Product Pipeline of formulations in development. With regulatory certifications from US-FDA, EDQM, COFEPRIS, ANVISA, MFDS-Korea, WHO-GMP, and ISO, Mac-Chem serves pharmaceutical customers in over 40 countries with a focus on supplying quality APIs to major oncology players for export to European markets.

Differentiator

Problem solved

Functional benefit

Brands

• Naprod: Product brand name used for formulation products including Anti-neoplastic, Anesthesia, and General Formulations product pipeline.

Products and services

• Oncology API Active Pharmaceutical Ingredients specifically for oncology treatments, including Abiraterone Acetate, Anastrozole, Azacitidine, Bendamustine Hydrochloride, Bicalutamide, Bortezomib, Cabazitaxel, Capecitabine, Carboplatin, Cisplatin, Cladribine, Cytarabine, Dacarbazine, Dasatinib, Docetaxel, Enzalutamide, Erlotinib, Etoposide, Exemestane, Fludarabine Phosphate, Gefitinib, Gemcitabine, Imatinib, Irinotecan, Lapatinib, Lenalidomide, Letrozole, Methotrexate, Oxaliplatin, Paclitaxel, Pemetrexed, Sorafenib, Sunitinib, Temozolomide, and Zoledronic Acid. Targeted at pharmaceutical companies manufacturing oncology formulations, with focus on the top 15 Oncology players in India for European market exports.
• Lyophilized Bulk Sterile API Lyophilized (freeze-dried) bulk sterile Active Pharmaceutical Ingredients for injectable formulations, including Acyclovir, Colistimethate Sodium, Chloramphenicol Sodium Succinate, Succinyl Choline Chloride, Tenoxicam, Polymyxin B, Esomeprazole Sodium, Omeprazole Sodium, Pantoprazole Sodium, Hydrocortisone Sodium Succinate, and Methylprednisolone Sodium Succinate. Used by pharmaceutical companies manufacturing sterile injectable products.
• General API General Active Pharmaceutical Ingredients across therapeutic categories including muscle relaxants (Suxamethonium Chloride, Vecuronium Bromide, Rocuronium Bromide), antibiotics (Colistimethate Sodium), anticholinesterases (Neostigmine Methylsulfate, Neostigmine Bromide), antiemetics (Aprepitant, Fosaprepitant), local anesthetics (Ropivacaine Hydrochloride), corticosteroids (Hydrocortisone Hemisuccinate, Methylprednisolone Base, Hydrocortisone Acetate), and sedatives (Dexmedetomidine Hydrochloride). Pipeline products include Caspofungin, Micafungin, Midazolam, Noradrenaline, Thiopental Sodium, Adrenaline, and Axitinib. Sold to generic pharmaceutical manufacturers across various therapeutic applications.
• Anti-neoplastic Formulations Finished dosage anti-neoplastic/cancer treatment formulations including tablets, capsules, and injectable products such as Abiraterone Acetate Tablets, Anastrozole Tablets, Arsenic Trioxide Injection, Bicalutamide Tablets, Bendamustine Hydrochloride Injection, Bortezomib Injection, Capecitabine Tablets, Carboplatin Injection, Cisplatin Injection, Cytarabine Injection, Dacarbazine, Daunorubicin Hydrochloride, Docetaxel Injection, Doxorubicin Hydrochloride Injection, Epirubicin Hydrochloride Injection, Erlotinib Tablets, Etoposide Injection, Everolimus Tablets, Fludarabine Phosphate Injection, Fluorouracil Injection, Gefitinib Tablets, Gemcitabine Injection, Imatinib Mesylate Tablets, Irinotecan Hydrochloride Injection, L-Asparaginase, Lenalidomide Capsules, Lapatinib Tablets, Methotrexate Injection/Tablets, Mitomycin Injection, Nilotinib Capsules, Oxaliplatin Injection, Paclitaxel Injection, Pemetrexed Injection, Plerixaflor Injection, Pazopanib Tablets, Temozolomide Capsules, Vinblastine Sulfate Injection, Vincristine Sulfate Injection, Ruxolitinib Tablets, and Sorafenib Tablets. Sold under the Naprod brand.
• Anesthesia Formulations Finished dosage anesthesia formulations in liquid and lyophilized injectable forms including Atracurium Besylate Injection, Bupivacaine Injection, Ketamine Hydrochloride Injection, Lignocaine and Adrenaline Injection, Lignocaine Injection, Propofol Injection, Rocuronium Bromide Injection, Succinylcholine Injection, Vecuronium Bromide Injection, Cisatracurium Injection, and Midazolam. Sold to pharmaceutical companies and healthcare institutions requiring anesthesia products.
• General Formulations Finished dosage general pharmaceutical formulations including lyophilized injectables such as Aciclovir Intravenous Infusion, Azithromycin for Injection, Clarithromycin for Infusion, Dobutamine for Injection, Esomeprazole Sodium for Injection, Fosaprepitant Dimenglumine for Injection, Nicorandil for Injection, Olanzapine for Injection, Omeprazole for Injection, Pantoprazole for Injection, Polymyxin B for Injection, Rabeprazole Sodium Injection, Iohexal, Vancomycin Hydrochloride for Intravenous Infusion, Voriconazole for Injection, Lornoxicam, Palonosetron, and Posaconazole Injection. Sold to pharmaceutical companies and healthcare distributors.
• Product Pipeline Future formulation products in development including Bendamustine RTU Injection (90mg/ml in 0.5ml and 2ml packs), Pralatraxate Injection (20mg/ml in 1ml and 2ml packs), Lapatinib 250mg Tablets, Dasatinib (20/50/70/100mg tablets), Nilotinib 200mg Capsules, Cisatracurium injection (2mg/ml and 10mg/ml), Clofarabine injection (20mg/20ml), Ibrutinib 140mg Capsules. Targeted at pharmaceutical partners and licensees in regulated and semi-regulated markets.

Quantifiable outcome

• Serving 40+ countries globally with presence across Asia, Europe, Latin America and Africa
• +3 more outcomes

Named customers14 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators9 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Neuland Laboratories: Indian CDMO and API manufacturer focused on small molecules for global pharma. Comparable to Mac-Chem in custom synthesis, complex chemistry, US-FDA inspected facilities, and serving innovator and generic customers.
• SMS Pharmaceuticals: Indian API manufacturer producing oncology and general APIs for global markets. Comparable to Mac-Chem in small-molecule API focus, oncology specialization, and supply to generic pharmaceutical customers.
• Laurus Labs: Indian API and formulation manufacturer with APIs in oncology, cardiovascular, and other therapeutic categories. Comparable to Mac-Chem in API manufacturing focus, regulated market exports, and vertical integration into finished dosage forms.
• Divi's Laboratories: India-based API and intermediates manufacturer with strong oncology and custom synthesis exposure. Comparable to Mac-Chem as a small-molecule API producer serving regulated global markets with significant R&D investment.
• Hikal: Indian API and CDMO manufacturer serving global pharmaceutical companies with focus on complex chemistries. Comparable to Mac-Chem in contract manufacturing, regulated-market supply, and pharma intermediates expertise.
• Aarti Drugs: Indian manufacturer of APIs and intermediates across therapeutic categories including oncology. Comparable to Mac-Chem in small-molecule API manufacturing scale and export orientation to regulated markets.
• Granules India: Indian pharmaceutical company manufacturing APIs and finished formulations with global exports. Comparable to Mac-Chem in API-plus-formulation model, regulated market presence, and cost-efficient manufacturing.

Broad incumbents

• Jubilant Pharmova: Indian integrated pharmaceuticals company with API, CDMO, and generics businesses serving global regulated markets. Comparable to Mac-Chem in small-molecule API manufacturing, US-FDA certified facilities, and diversified pharmaceutical offerings.
• Aurobindo Pharma: Large Indian vertically-integrated generics manufacturer with significant API manufacturing operations and oncology exposure. Comparable to Mac-Chem in oncology API supply and global pharmaceutical distribution, though much larger in scale and scope.
• Piramal Pharma Solutions: Global CDMO offering API manufacturing services across complex small molecules and sterile fill-finish. Comparable to Mac-Chem in API contract manufacturing, lyophilization capabilities, and serving global pharma customers from India.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/naprod-life-science-pvt.-ltd

Compliance9 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mac-Chem